Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress IMKTA Q1 2026 Earnings Strong EPS Performance Despite Modest Market Reaction Latham Group SWIM Q1 2026 Earnings EPS Surprise Drives Shares Higher Dynatrace DT Q1 2026 Earnings Software Firm Beats EPS Expectations Shares Gain 53 FGBIP Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Edges Lower Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues